CN113080468A - Slow-digestion casein nano micelle powder and preparation method thereof - Google Patents
Slow-digestion casein nano micelle powder and preparation method thereof Download PDFInfo
- Publication number
- CN113080468A CN113080468A CN202110396218.3A CN202110396218A CN113080468A CN 113080468 A CN113080468 A CN 113080468A CN 202110396218 A CN202110396218 A CN 202110396218A CN 113080468 A CN113080468 A CN 113080468A
- Authority
- CN
- China
- Prior art keywords
- casein
- powder
- radio frequency
- nanomicelle
- nano
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 title claims abstract description 116
- 235000021240 caseins Nutrition 0.000 title claims abstract description 107
- 239000005018 casein Substances 0.000 title claims abstract description 106
- 239000000693 micelle Substances 0.000 title claims abstract description 79
- 239000000843 powder Substances 0.000 title claims abstract description 52
- 238000002360 preparation method Methods 0.000 title claims abstract description 23
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 39
- 238000000034 method Methods 0.000 claims abstract description 25
- 159000000007 calcium salts Chemical class 0.000 claims abstract description 15
- 238000001035 drying Methods 0.000 claims abstract description 12
- 102000011632 Caseins Human genes 0.000 claims description 107
- 108010076119 Caseins Proteins 0.000 claims description 107
- 239000000243 solution Substances 0.000 claims description 17
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 12
- 239000008055 phosphate buffer solution Substances 0.000 claims description 12
- 235000013305 food Nutrition 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 239000001506 calcium phosphate Substances 0.000 claims description 9
- 229910000389 calcium phosphate Inorganic materials 0.000 claims description 9
- 229960001714 calcium phosphate Drugs 0.000 claims description 9
- 235000011010 calcium phosphates Nutrition 0.000 claims description 9
- 239000011259 mixed solution Substances 0.000 claims description 9
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 9
- 102000009366 Alpha-s1 casein Human genes 0.000 claims description 8
- 108050000244 Alpha-s1 casein Proteins 0.000 claims description 8
- 108050001786 Alpha-s2 casein Proteins 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- 238000009210 therapy by ultrasound Methods 0.000 claims description 8
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 6
- 229960003563 calcium carbonate Drugs 0.000 claims description 6
- 235000010216 calcium carbonate Nutrition 0.000 claims description 6
- 239000004227 calcium gluconate Substances 0.000 claims description 6
- 229960004494 calcium gluconate Drugs 0.000 claims description 6
- 235000013927 calcium gluconate Nutrition 0.000 claims description 6
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 claims description 6
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 claims description 5
- 239000001527 calcium lactate Substances 0.000 claims description 5
- 235000011086 calcium lactate Nutrition 0.000 claims description 5
- 229940041131 calcium lactate gluconate Drugs 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 5
- 238000000926 separation method Methods 0.000 claims description 4
- 235000021246 κ-casein Nutrition 0.000 claims description 4
- 239000003937 drug carrier Substances 0.000 claims description 3
- 239000008363 phosphate buffer Substances 0.000 claims description 3
- 235000021247 β-casein Nutrition 0.000 claims description 3
- 235000013402 health food Nutrition 0.000 claims description 2
- 235000013350 formula milk Nutrition 0.000 claims 1
- 230000007062 hydrolysis Effects 0.000 abstract description 16
- 238000006460 hydrolysis reaction Methods 0.000 abstract description 16
- 235000018102 proteins Nutrition 0.000 abstract description 10
- 102000004169 proteins and genes Human genes 0.000 abstract description 10
- 108090000623 proteins and genes Proteins 0.000 abstract description 10
- 102000057297 Pepsin A Human genes 0.000 abstract description 9
- 108090000284 Pepsin A Proteins 0.000 abstract description 9
- 230000002209 hydrophobic effect Effects 0.000 abstract description 9
- 229940111202 pepsin Drugs 0.000 abstract description 9
- 239000002245 particle Substances 0.000 abstract description 8
- 102000004142 Trypsin Human genes 0.000 abstract description 7
- 108090000631 Trypsin Proteins 0.000 abstract description 7
- 239000012588 trypsin Substances 0.000 abstract description 7
- 230000005012 migration Effects 0.000 abstract description 4
- 238000013508 migration Methods 0.000 abstract description 4
- 238000001338 self-assembly Methods 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 3
- 230000036541 health Effects 0.000 abstract description 3
- 235000016709 nutrition Nutrition 0.000 abstract description 3
- 230000035764 nutrition Effects 0.000 abstract description 3
- 201000010099 disease Diseases 0.000 abstract description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 2
- 235000013376 functional food Nutrition 0.000 abstract description 2
- 210000003205 muscle Anatomy 0.000 abstract description 2
- 208000008589 Obesity Diseases 0.000 abstract 1
- 230000018044 dehydration Effects 0.000 abstract 1
- 238000006297 dehydration reaction Methods 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- 102000035195 Peptidases Human genes 0.000 description 17
- 108091005804 Peptidases Proteins 0.000 description 17
- 239000004365 Protease Substances 0.000 description 17
- 230000029087 digestion Effects 0.000 description 14
- 230000000052 comparative effect Effects 0.000 description 11
- 230000000694 effects Effects 0.000 description 9
- 238000004108 freeze drying Methods 0.000 description 8
- 239000012071 phase Substances 0.000 description 8
- 210000004051 gastric juice Anatomy 0.000 description 7
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 6
- 235000020247 cow milk Nutrition 0.000 description 6
- 238000003760 magnetic stirring Methods 0.000 description 6
- 230000017854 proteolysis Effects 0.000 description 6
- 229920001577 copolymer Polymers 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 238000002604 ultrasonography Methods 0.000 description 5
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 4
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 4
- 230000002378 acidificating effect Effects 0.000 description 4
- 229910001424 calcium ion Inorganic materials 0.000 description 4
- 238000010292 electrical insulation Methods 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- -1 hydrogen ions Chemical class 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 229920001169 thermoplastic Polymers 0.000 description 4
- 150000001768 cations Chemical class 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 238000004925 denaturation Methods 0.000 description 3
- 230000036425 denaturation Effects 0.000 description 3
- 230000010355 oscillation Effects 0.000 description 3
- 230000026731 phosphorylation Effects 0.000 description 3
- 238000006366 phosphorylation reaction Methods 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical group [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 229960005069 calcium Drugs 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000009881 electrostatic interaction Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 239000002088 nanocapsule Substances 0.000 description 2
- 239000011858 nanopowder Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000007065 protein hydrolysis Effects 0.000 description 2
- 238000004088 simulation Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- VYIRVAXUEZSDNC-TXDLOWMYSA-N (3R,3'S,5'R)-3,3'-dihydroxy-beta-kappa-caroten-6'-one Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC(=O)[C@]1(C)C[C@@H](O)CC1(C)C VYIRVAXUEZSDNC-TXDLOWMYSA-N 0.000 description 1
- VYIRVAXUEZSDNC-LOFNIBRQSA-N Capsanthyn Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC(=O)C2(C)CC(O)CC2(C)C VYIRVAXUEZSDNC-LOFNIBRQSA-N 0.000 description 1
- 102000008934 Muscle Proteins Human genes 0.000 description 1
- 108010074084 Muscle Proteins Proteins 0.000 description 1
- 229920002494 Zein Polymers 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000655 anti-hydrolysis Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- WRANYHFEXGNSND-LOFNIBRQSA-N capsanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC(=O)C2(C)CCC(O)C2(C)C WRANYHFEXGNSND-LOFNIBRQSA-N 0.000 description 1
- 235000018889 capsanthin Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229940021722 caseins Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000000280 densification Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000001688 paprika extract Substances 0.000 description 1
- 235000012658 paprika extract Nutrition 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical class [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 235000005974 protein supplement Nutrition 0.000 description 1
- 229940116540 protein supplement Drugs 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 239000005019 zein Substances 0.000 description 1
- 229940093612 zein Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/015—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/03—Organic compounds
- A23L29/035—Organic compounds containing oxygen as heteroatom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/30—Physical treatment, e.g. electrical or magnetic means, wave energy or irradiation
- A23L5/32—Physical treatment, e.g. electrical or magnetic means, wave energy or irradiation using phonon wave energy, e.g. sound or ultrasonic waves
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/30—Physical treatment, e.g. electrical or magnetic means, wave energy or irradiation
- A23L5/36—Physical treatment, e.g. electrical or magnetic means, wave energy or irradiation using irradiation with frequencies of more than 10 MHz
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Inorganic Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dispersion Chemistry (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention discloses slowly digestible casein nano micelle powder and a preparation method thereof, and belongs to the field of nutrition and health. The casein nano micelle powder takes casein, calcium salt and citric acid as initial suspension, a specific three-dimensional network structure is formed under ultrasonic crushing, the self-assembly of nano micelles is realized by matching with space charge migration and collision induced by radio frequency, and the novel casein nano micelle powder with uniform and tiny particle size is prepared after freeze dehydration and drying. The novel casein nano micelle powder prepared by the method has obvious hydrolysis resistance to pepsin and trypsin, so that the novel casein nano micelle powder has the characteristic of continuously providing protein and energy, can maintain the muscle state and slowly release encapsulated hydrophobic functional food or medicine, and provides a new solution for body-building people, obesity people and disease treatment.
Description
Technical Field
The invention relates to slowly digestible casein nano micelle powder and a preparation method thereof, belonging to the field of nutrition and health.
Background
With the development of science and technology and the improvement of the knowledge level of people, the close relationship between diet and health is valued by people, and the opportunities and challenges facing the food industry and the medical field are followed, including the development of new protein supplements and protein carriers in the medical field.
Research shows that casein can continuously provide protein for athletes, help athletes inhibit protein decomposition, and release amino acids into blood, so as to improve metabolism rate and promote muscle protein synthesis. In addition, because the hydrophilic and hydrophobic residues in the casein polypeptide chain are distributed in clusters, the casein molecule has a blocky amphiphilic structure. By utilizing the natural conformation, the casein serves as a nano capsule, the solubility and the stability of the hydrophobic nutrient substance are improved by the targeted delivery of the hydrophobic nutrient substance, the hydrophobic nutrient substance can be slowly released in vivo, the bioavailability in vivo of the hydrophobic nutrient substance is enhanced, and the like.
However, casein structures are susceptible to hydrolysis by proteases due to the presence of high levels of proline, but low levels of cysteine residues. Although casein molecules have a blocky amphiphilic structure and phosphorylation centers, which can spontaneously form spherical casein micelles by self-association and interaction with colloidal calcium phosphate, studies have shown that in vitro digestion simulation experiments, the addition of a certain amount of pepsin in simulated gastric juice at pH 2.5, a large portion of casein is digested and decomposed within 120min of the study. Meanwhile, because a large amount of hydrogen ions exist in gastric juice, nano-micelles formed by casein are gradually dissociated along with the increase of acidity, kappa-casein 'hair layers' on the surfaces of the micelles gradually collapse, and the spatial distribution of the casein in the internal structures of the micelles changes, so that the casein micelles cannot maintain the spatial structures of the casein micelles, and the casein micelles are more easily hydrolyzed by protease.
Some studies on the improvement of the stability and the slowing of the digestion rate of casein have been reported, and multiple emulsion aggregation method, polysaccharide grafting method and the like are commonly used for enhancing the resistance of casein to protease. For example, chenghao (functional factor co-embedding research based on different carriers of casein/zein, university of south of the Yangtze river, 2020) and the like prepare the nano compound which takes casein as a core and realizes the embedding of alpha-tocopherol by adding an emulsifier, and the nano compound has a good slow release effect, however, the casein digestion rate is still high, and the prepared particle size is large, so that the production application cannot be expanded. Min Min (preparation of glycosylated casein, performance and application research of the glycosylated casein, Zhejiang university of industry and commerce, 2017) and the like adopt chitosan and carrageenan to graft casein under the condition of ultrasonic dry heat to obtain the glycosylated casein, however, the digestion rate of the nanocapsule in simulated gastric juice is still high, nearly 60% of capsanthin pigment is released within 90Min, and the resistance of the casein to protease is weak.
However, for the related solutions such as the multiple emulsion aggregation method and the polysaccharide grafting method, for example, the polysaccharide grafting method grafts proteins with the components that are not easily digested by pepsin such as polysaccharide, so as to form a polysaccharide-protein complex, in the presence of gastric acid, the casein micelles with the existing structure still cause dissolution of calcium ions, so as to cause collapse of the nano-micelles, so that the nano-micelles are more easily hydrolyzed by protease, and the technical problems that casein is easily hydrolyzed by protease in gastric juice and the digestion rate is higher are not effectively improved.
In summary, in order to improve the stability of casein and slow down the digestion rate of casein, research and development of slowly digested casein nano micelle powder is an urgent need in the fields of food nutrition, medical care and the like.
Disclosure of Invention
The purpose of the invention is as follows: aiming at the problems, in order to overcome the defects in the prior art, the slowly digestible casein nano micelle powder and the preparation method thereof are developed, the prepared casein nano micelle powder can resist protease hydrolysis, and has a slow release effect and a slow decomposition characteristic in the casein digestion process; the casein nano micelle has uniform particle size, no toxic or side effect and good industrial application prospect.
In view of the above, the problems of casein as a protein carrier are: is easy to be hydrolyzed by protease in gastric juice and has high digestion rate. In contrast, according to the invention, the forming route of the nano-micelle is reasonably designed again, acidic calcium salt of any one or a combination of more of calcium phosphate, calcium carbonate, calcium lactate and calcium gluconate is added into casein-phosphate buffer solution, citric acid is used for adjusting the pH value of the solution, and casein and calcium ions form a compact three-dimensional network structure through phosphorylation centers, calcium bridging, electrostatic interaction and the like. Meanwhile, under the action of ultrasound, the hydrophobic cavity inside the nano micelle becomes more compact, and the pores of the micelle become smaller. In addition, the invention further adopts a radio frequency device to process the casein nano-micelle, utilizes the high-frequency alternating electromagnetic wave of the radio frequency to induce the oscillation and migration of cations such as calcium ions, hydrogen ions and the like in the casein micelle, on one hand, the exposed proline generates certain degree of thermal denaturation to trigger the self-assembly of the nano-micelle, thereby generating resistance to the hydrolysis of protease, and on the other hand, the hydrated particle size of the nano-micelle is reduced to be in a state of uniform and tiny particle size. Finally, the aqueous phase is subjected to freeze drying, normal pressure drying or reduced pressure drying, and the obtained casein nano-micelle can generate a shielding effect on the hydrolysis of protease, namely the digestion rate in gastric juice is slowed down. The casein nano-micelle prepared by the principle and having slow decomposition and slow release effects has uniform particle size, no toxic or side effect and good industrial application prospect.
The technical scheme is as follows: the invention adopts the following technical scheme.
The invention aims to provide a preparation method of slowly digestible casein nano micelle powder, in particular to a preparation method of casein nano micelle powder capable of resisting protease hydrolysis, and the specific scheme is as follows:
(1) adding casein, calcium salt and citric acid into a phosphate buffer solution, and performing ultrasonic treatment on the stirred mixed solution;
(2) performing radio frequency treatment on the mixed solution obtained in the step (1), stirring and standing;
(3) and (3) carrying out solid-liquid separation on the solution obtained in the step (2), and drying the obtained water phase to obtain the casein nano micelle powder.
In one embodiment of the invention, the casein in step (1) is derived from any one or more of α s 1-casein, α s 2-casein, β -casein and κ -casein. The alpha s 1-casein and alpha s 2-casein are casein in common cow milk and are easy to obtain.
In one embodiment of the present invention, the calcium salt in step (1) includes any one or more of calcium phosphate, calcium carbonate, calcium lactate, and calcium gluconate.
In one embodiment of the invention, the mass ratio of the casein to the calcium salt in the step (1) is 10 (1-5), and the total concentration of the casein and the calcium salt in the mixed solution is 2% -4.5% (w/v).
In one embodiment of the invention, the mass ratio of casein to citric acid in the step (1) is 20 (1-10).
In one embodiment of the present invention, the phosphate buffer in step (1) has a pH of 7.4 and a concentration of 1 to 100mM,
in one embodiment of the present invention, the concentration of the phosphate buffer in step (1) is 20 to 80 mM.
In one embodiment of the present invention, the ultrasonic treatment conditions in the step (1) are: the ultrasonic power is 50-200w, and the ultrasonic time is 5-20 min.
In one embodiment of the present invention, the radio frequency processing device applied in step (2) is a radio frequency device equipped with a hot air auxiliary system, and the resonance frequency of the radio frequency device is one of 13.56MHz, 27.12MHz and 40.68 MHz.
In one embodiment of the invention, the radio frequency output power in the step (2) is 1.0-8.0 kW.
In one embodiment of the present invention, the inter-plate distance of the radio frequency device in the step (2) is 40-120 mm.
In one embodiment of the present invention, the container of the radio frequency device in the step (2) is a thermoplastic basket with good electrical insulation.
In one embodiment of the invention, the temperature of the hot air auxiliary in the radio frequency device in the step (2) is 50-55 ℃.
In one embodiment of the present invention, the rf processing time in the step (2) is 100-.
In one embodiment of the present invention, the drying in the step (3) includes any one of freeze drying, atmospheric drying or reduced pressure drying.
It is another object of the present invention to provide a slowly digestible casein micelle powder prepared using the above method.
The invention also aims to apply the slowly digestible casein micelle powder to the fields of preparing common foods, health-care foods, special medical formula foods, drug carriers and the like.
The invention has the beneficial effects that:
(1) according to the method, acidic calcium salts such as calcium phosphate, calcium carbonate, calcium lactate and calcium gluconate are adopted, the pH value of a casein aqueous solution is adjusted by adding citric acid, and the three-dimensional network structure of the casein nano-micelle is redefined under the assistance of ultrasound, so that a hydrophobic cavity in the casein nano-micelle becomes more compact, and the pores of the micelle are reduced;
(2) the casein nano-micelle is treated by high-frequency alternating-current electromagnetic waves, cation oscillation migration such as calcium ions, hydrogen ions and the like in the micelle is induced, proline exposed on the surface of the micelle generates certain thermal denaturation, the nano-micelle is initiated to be self-assembled again, and the novel slow-digestion casein nano-micelle with small hydrated particle size and uniform structure is formed and has certain digestion resistance in the protease hydrolysis process;
(3) the raw materials of the slow-digestion casein nano micelle powder prepared by the invention are all food grade, and the slow-digestion casein nano micelle powder can be applied to the food fields of common food, health food, special medical formula food and the like and the medicine fields of drug carriers and the like. It can provide protein continuously, also can provide anti-hydrolysis characteristic, maintain muscle state, slowly release encapsulated hydrophobic functional food or drug, and provide new solution for body-building people, obese people and disease treatment.
Drawings
Fig. 1 is a schematic diagram of the preparation of slowly digestible casein nano micelle powder, wherein the solid-liquid separation and drying processes are not shown in the figure, but the understanding of ultrasonic and radio frequency treatment is not affected.
Detailed Description
The invention provides casein nano micelle powder capable of resisting protease hydrolysis and a preparation method thereof, and the specific scheme of the preparation method is as follows:
(1) dissolving casein and calcium salt in phosphate buffer solution with a certain volume, adding a certain amount of citric acid, magnetically stirring for 5-10 min, and treating the mixed solution by using ultrasound;
(2) putting the mixed solution obtained in the step (1) into a radio frequency device with a treatment cavity for radio frequency treatment, continuously stirring for 15-20 min, and standing;
(3) and (3) carrying out solid-liquid separation on the mixed solution obtained in the step (2), removing redundant undissolved calcium salt, and drying the water phase to obtain the casein nano micelle powder product.
The following description of the preferred embodiments of the present invention is provided for the purpose of better illustrating the invention and is not intended to limit the invention thereto.
Example 1
A slowly digestible casein nano micelle powder and its preparation method are provided. The method comprises the following specific steps:
(1) 10g of alpha s 1-casein, 10g of alpha s 2-casein and 2g of calcium phosphate are taken from cow milk, dispersed in 500mL of 20mM phosphate buffer solution with pH7.4, 5g of citric acid is added, magnetic stirring is carried out for 5min, and then ultrasonic treatment is carried out for 5min at 100 w.
(2) Slowly adding the solution obtained in the step (1) into a thermoplastic plastic basket with good electrical insulation, wherein the radio frequency working frequency is 27.12MHz, the power is set to be 5kW, the distance between polar plates is 45mm, the auxiliary temperature in a radio frequency treatment device is set to be 55 ℃, and the treatment time is 300 s. Followed by magnetic stirring for 15 min.
(3) And (3) separating the water phase in the step (2), and freeze-drying the water phase to obtain the slow-digestion casein nano micelle powder.
Example 2
A slowly digestible casein nano micelle powder and its preparation method are provided. The method comprises the following specific steps:
(1) dispersing 5g of alpha s 1-casein, 7g of alpha s 2-casein, 9g of beta-casein, 4g of kappa-casein and 8g of calcium carbonate in 800mL of 80mM phosphate buffer solution with pH7.4, adding 4g of citric acid, magnetically stirring for 5min, and treating for 16min by ultrasonic treatment at 200 w.
(2) Slowly adding the solution obtained in the step (1) into a thermoplastic plastic basket with good electrical insulation, wherein the radio frequency working frequency is 40.68MHz, the power is set as 8kW, the distance between polar plates is 100mm, the auxiliary temperature in a radio frequency treatment device is set as 55 ℃, and the treatment time is 400 s. Followed by magnetic stirring for 15 min.
(3) And (3) separating the water phase in the step (2), and drying at normal pressure to obtain the slowly digestible casein nano powder.
Example 3
A slowly digestible casein nano micelle powder and its preparation method are provided. The method comprises the following specific steps:
(1) 20g of commercial cow milk composite casein (a composite of various caseins) and 8g of calcium gluconate are dispersed in 900mL of 55mM phosphate buffer solution with pH7.4, 10g of citric acid is added, magnetic stirring is carried out for 5min, and ultrasonic treatment is carried out for 17min at 120 w.
(2) Slowly adding the solution obtained in the step (1) into a thermoplastic plastic basket with good electrical insulation, wherein the radio frequency working frequency is 13.56MHz, the power is set to be 8kW, the distance between polar plates is 60mm, the auxiliary temperature in a radio frequency treatment device is set to be 55 ℃, and the treatment time is 500 s. Followed by magnetic stirring for 15 min.
(3) And (3) separating the water phase in the step (2), concentrating, and drying under reduced pressure to obtain the slowly digestible casein nano powder.
To better explain the remarkable effects of the present invention, the comparative examples were added as follows:
comparative example 1
The preparation method is the same as example 1, except that the preparation method of casein micelle powder without radio frequency treatment comprises the following specific steps:
a slowly digestible casein nano micelle powder and its preparation method are provided. The method comprises the following specific steps:
(1) dispersing 10g of cow milk alpha s 1-casein, 10g of alpha s 2-casein and 2g of calcium phosphate in 500mL of 20mM phosphate buffer solution with pH of 7.4, adding 5g of citric acid, magnetically stirring for 5min, and treating for 5min by using 100w of ultrasound.
(2) And (2) separating the water phase in the step (1), concentrating, and freeze-drying to obtain the slow-digestion casein nano micelle powder.
Comparative example 2
The preparation method is the same as example 1, except that casein micelle powder without ultrasonic and radio frequency treatment is prepared, and the specific steps are as follows:
(1) 10g of alpha s 1-casein, 10g of alpha s 2-casein and 2g of calcium phosphate are taken from cow milk, dispersed in 500mL of 20mM phosphate buffer solution with pH7.4, 5g of citric acid is added, and magnetic stirring is carried out for 5 min.
(2) And (2) concentrating the solution obtained in the step (1), and freeze-drying the concentrated solution to obtain casein nano micelle powder.
Comparative example 3
Casein micelle powder was prepared by a conventional glycosylation method. The method comprises the following specific steps:
(1) taking 10g of cow milk alpha s 1-casein and 10g of alpha s 2-casein, dissolving in 20mL of phosphate buffer solution with pH7.4, stirring for 2.5h at room temperature, inserting an ultrasonic instrument probe into the position 2cm below the protein liquid surface, carrying out ice bath treatment for 30min under the condition of power 100W, collecting a sample, adding 10g of chitosan, uniformly mixing, freeze-drying for 48h, grinding the sample into powder, sieving the powder (120 meshes), placing the powder into a 25mL small beaker, placing the beaker into a reaction container (relative humidity is 80%) containing saturated potassium bromide, controlling the reaction temperature at 70 ℃, reacting for 30min, and cooling to terminate the reaction.
(2) And (2) removing the water phase of the micelle obtained in the step (1), concentrating, and freeze-drying to obtain the glycosylated casein copolymer.
(3) And (3) dissolving the glycosylated casein copolymer obtained in the step (2) in a phosphate buffer solution with the pH value of 7.4 to prepare a copolymer solution with the final concentration of 2mg/mL, placing the copolymer solution in a thermostatic water bath at the temperature of 25 ℃, stirring for 3 hours, and then transferring the copolymer solution to a refrigerator at the temperature of 4 ℃ for standing for 12 hours. Then carrying out ultrasonic treatment at 100W for 6min under ice bath conditions to obtain a glycosylated casein micelle solution.
(4) And (4) concentrating the glycosylated casein micelle solution obtained in the step (3), and freeze-drying to obtain glycosylated casein micelle powder.
Comparison of product characteristics of examples and comparative examples:
the degree of hydrolysis of protein is an important index for evaluating the degree of digestion of protein, and the degree of hydrolysis of protein is tested by an in vitro digestion simulation method.
First, the degree of proteolysis by pepsin hydrolysis was determined: the casein micelle powder solutions prepared in the above-mentioned specific examples and comparative examples were hydrolyzed using pepsin in an amount of 5% by mass of the total protein, and the activity was 8 × 104U/g, degree of proteolysis was determined after hydrolysis.
Subsequently, the degree of proteolysis by trypsin hydrolysis was determined: adjusting pH of the solution to 7.0, hydrolyzing with trypsin in an amount of 10% of total protein content, and activating to 3.9 × 105U/g, degree of proteolysis was determined after hydrolysis.
The test results are shown in tables 1 and 2 (blank is casein without any treatment):
TABLE 1 degree of proteolysis of different samples by pepsin
TABLE 2 further degree of proteolysis of different samples by trypsin
According to the data in the tables 1 and 2, the sample obtained by the conventional casein nano micelle preparation method is the comparative example 2, and the test result shows that the sample has almost no resistance to two proteases and is rapidly hydrolyzed under the treatment of the two proteases; while comparative example 3 is a glycosylated casein nanomicelle prepared using glycosylated casein, which is only slightly resistant to hydrolysis by pepsin and trypsin.
Compared with the comparative example and the blank group, the hydrolysis degree of the casein nano-micelle powder prepared by the embodiment 1-3 is obviously lower than that of the comparative example and the blank group by adopting the technical scheme of the invention, and the casein nano-micelle powder prepared by the embodiment 1-3 has higher resistance to pepsin and trypsin, particularly the casein nano-micelle powder prepared by the embodiment 2 has the hydrolysis degree greatly reduced by 80 percent compared with the blank group and the comparative example, which fully verifies that the treatment process of reconstructing a three-dimensional network structure by using the acidic calcium salt, performing ultrasonic densification and performing radio frequency induced self-assembly effectively improves the technical problems that the casein is easy to hydrolyze by protease in gastric juice and has higher digestion rate, and has obvious promotion effect on improving the stability of the casein and slowing down the digestion rate.
In the invention, acidic calcium salt of any one or a plurality of combinations of calcium phosphate, calcium carbonate, calcium lactate and calcium gluconate is added into casein-phosphate buffer solution, and casein and calcium ions form a compact three-dimensional network structure through phosphorylation centers, calcium bridging, electrostatic interaction and the like. Meanwhile, the hydrophobic cavity inside the nano micelle becomes more compact by ultrasound, and the pore of the micelle is reduced; in addition, radio frequency self high frequency alternating current electromagnetic waves are utilized to induce the oscillation migration of cations such as calcium ions, hydrogen ions and the like in the casein micelles, on one hand, exposed proline is subjected to certain thermal denaturation to trigger the self-assembly of the nano micelles again, so that the resistance is generated to the hydrolysis of protease, and on the other hand, the hydrated particle size of the nano micelles is reduced to be in a uniform and micro particle size state.
In conclusion, the casein nano micelle powder prepared by the invention is only partially hydrolyzed under the treatment of pepsin and trypsin, and a slowly digested casein nano micelle powder product is successfully prepared.
The above description is only of the preferred embodiments of the present invention, and it should be noted that: it will be apparent to those skilled in the art that various modifications and adaptations can be made without departing from the principles of the invention and these are intended to be within the scope of the invention.
Claims (10)
1. A preparation method of slowly digestible casein nano micelle powder is characterized by comprising the following steps:
(1) adding casein, calcium salt and citric acid into a phosphate buffer solution, and performing ultrasonic treatment on the stirred mixed solution;
(2) performing radio frequency treatment on the mixed solution obtained in the step (1), stirring and standing;
(3) and (3) carrying out solid-liquid separation on the solution obtained in the step (2), and drying the obtained water phase to obtain the casein nano micelle powder.
2. The method for preparing slowly digestible casein nanomicelle powder according to claim 1, wherein the casein in step (1) comprises any one or more of α s 1-casein, α s 2-casein, β -casein and/or κ -casein.
3. The method for preparing slowly digestible casein nanomicelle powder according to claim 1, wherein the calcium salt in step (1) comprises any one or more of calcium phosphate, calcium carbonate, calcium lactate, and calcium gluconate.
4. The preparation method of the slowly digestible casein nanomicelle powder according to claim 1, wherein the mass ratio of the casein to the calcium salt in step (1) is 10 (1-5), and the total concentration of the casein and the calcium salt in the mixed solution is 2-4.5% (w/v).
5. The preparation method of the slowly digestible casein nanomicelle powder according to claim 1, wherein the mass ratio of casein to citric acid in step (1) is 20 (1-10).
6. The method for preparing slowly digestible casein nanomicelle powder according to claim 1, wherein the phosphate buffer in step (1) has a pH of 7.4 and a concentration of 1-100mM, preferably 20-80 mM.
7. The method for preparing slowly digestible casein nanomicelle powder according to claim 1, wherein the ultrasonic treatment in step (1) is performed under the following conditions: the ultrasonic power is 50-200w, and the ultrasonic time is 5-20 min.
8. The method for preparing slowly digestible casein nanomicelle powder according to claim 1, wherein the radio frequency treatment in step (2) is performed by using a radio frequency device equipped with a hot air auxiliary system, the resonance frequency of the radio frequency device is one of 13.56MHz, 27.12MHz and 40.68MHz, and the radio frequency treatment conditions are as follows: the radio frequency output power is 1.0-8.0kW, the distance between the electrode plates is 40-120mm, the hot air auxiliary temperature is 50-55 ℃, and the treatment time is 100-500 s.
9. Casein nanomicelle powder obtainable by the process according to any one of claims 1 to 8.
10. Use of the casein nano-micelle powder of claim 9 in the preparation of general food, health food, formula food for special medical use, and drug carrier.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110396218.3A CN113080468B (en) | 2021-04-13 | 2021-04-13 | Slow-digestion casein nano micelle powder and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110396218.3A CN113080468B (en) | 2021-04-13 | 2021-04-13 | Slow-digestion casein nano micelle powder and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113080468A true CN113080468A (en) | 2021-07-09 |
CN113080468B CN113080468B (en) | 2022-09-06 |
Family
ID=76676849
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110396218.3A Active CN113080468B (en) | 2021-04-13 | 2021-04-13 | Slow-digestion casein nano micelle powder and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113080468B (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114947108A (en) * | 2022-04-28 | 2022-08-30 | 中国农业大学 | Casein micelle accurate controlled-release composition and preparation method thereof |
CN115005320A (en) * | 2022-05-07 | 2022-09-06 | 中国农业大学 | Preparation method of casein powder with long-acting satiety and obtained product |
WO2023151198A1 (en) * | 2022-02-10 | 2023-08-17 | 江南大学 | Casein micelle having compositional and structural features imitating human milk and preparation method therefor |
WO2023230648A1 (en) * | 2022-05-30 | 2023-12-07 | All G Foods Holdings Pty Limited | Compositions |
US11963542B2 (en) | 2022-02-10 | 2024-04-23 | Jiangnan University | Casein micelle with composition and structural features simulating human milk and preparation method thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109480291A (en) * | 2018-11-19 | 2019-03-19 | 浙江工商大学 | Casein-carboxymethyl chitosan glycosylation nanoparticle preparation and its application |
-
2021
- 2021-04-13 CN CN202110396218.3A patent/CN113080468B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109480291A (en) * | 2018-11-19 | 2019-03-19 | 浙江工商大学 | Casein-carboxymethyl chitosan glycosylation nanoparticle preparation and its application |
Non-Patent Citations (3)
Title |
---|
MIN YANG,ET AL.: "Effect of ultrasound pretreatment on the physicochemical properties and simulated gastrointestinal digestibility of micellar casein concentrates", 《FOODSCIENCEANDTECHNOLOGY》 * |
韩丹等: "酪蛋白作为药物纳米递送载体的研究进展", 《中国新药杂志》 * |
高芸芳等: "酪蛋白结构及其酶解特性研究进展", 《农产品加工(学刊)》 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023151198A1 (en) * | 2022-02-10 | 2023-08-17 | 江南大学 | Casein micelle having compositional and structural features imitating human milk and preparation method therefor |
US11963542B2 (en) | 2022-02-10 | 2024-04-23 | Jiangnan University | Casein micelle with composition and structural features simulating human milk and preparation method thereof |
CN114947108A (en) * | 2022-04-28 | 2022-08-30 | 中国农业大学 | Casein micelle accurate controlled-release composition and preparation method thereof |
CN115005320A (en) * | 2022-05-07 | 2022-09-06 | 中国农业大学 | Preparation method of casein powder with long-acting satiety and obtained product |
CN115005320B (en) * | 2022-05-07 | 2023-09-05 | 中国农业大学 | Preparation method of casein powder with long-acting satiety and obtained product |
WO2023230648A1 (en) * | 2022-05-30 | 2023-12-07 | All G Foods Holdings Pty Limited | Compositions |
Also Published As
Publication number | Publication date |
---|---|
CN113080468B (en) | 2022-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113080468B (en) | Slow-digestion casein nano micelle powder and preparation method thereof | |
Ketnawa et al. | Effect of microwave treatments on antioxidant activity and antigenicity of fish frame protein hydrolysates | |
Lv et al. | Modification methods and applications of egg protein gel properties: A review | |
CN107549443B (en) | Preparation method of composite protein foaming agent | |
AU2020103452A4 (en) | Method for preparing liquid milk based on reduced allergenicity of cow's milk | |
Chen et al. | Recent advances in modified food proteins by high intensity ultrasound for enhancing functionality: Potential mechanisms, combination with other methods, equipment innovations and future directions | |
CN109673814A (en) | A kind of preparation method of the compound protein powder of homoamino acid scoring | |
CN107298863A (en) | The supersonically preparation method of peanut protein polysaccharide composite particle and functional food application | |
CN108719576A (en) | It is a kind of to be ultrasonically treated the preparation method for improving functional whey protein characteristic | |
CN107254181A (en) | The application of the supersonically preparation method and functional food of casein polysaccharide nanogel | |
CN103565839A (en) | Method for separating and extracting pig placentin | |
CN108003219A (en) | A kind of can improve cracks rice protein extracting ratio and carries out the method for glycosylation modification to it | |
Zou et al. | Effect of ultrasound assisted konjac glucomannan treatment on properties of chicken plasma protein gelation | |
CN111549084B (en) | Method for preparing protein small molecule peptide by simulating human body digestive tract enzymolysis | |
Wang et al. | The improvement and mechanism of gelation properties of mung bean protein treated by ultrasound | |
CN103444979A (en) | Method for lowering albumen allergenicity by immobilized enzyme hydrolysis | |
CN111990639A (en) | Method for preparing SPH-EGCG compound by using polyphenol precipitation hydrolysis peptide | |
CN114601013B (en) | Casein micelle with structural characteristics similar to human milk and preparation method thereof | |
Liu et al. | Effects of synergistic modification with enzymatic hydrolysis and phosphorylation on functional and structural properties of ovalbumin | |
CN104789622A (en) | Low-sensitization low-fishy-smell fish protein peptide whole powder, and industrialized preparation method and application thereof | |
CN109293766A (en) | The method of collagen polypeptide is extracted from fish scale | |
CN103966292A (en) | Industrial manufacturing method and use of allergen-eliminated partly appropriately-hydrolyzed casein peptide | |
Asaithambi et al. | Influence of hydrodynamic cavitation on functional, nutritional, and structural characteristics of egg-white protein hydrolysates | |
CN112167543A (en) | Oxidative damage protein gel performance repairing method based on lysine-glutamine transaminase | |
CN107338278A (en) | The method that ultrasonic in combination simulation digestion prepares collagen gel antioxidation polypeptide liquid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |